, associated the substitutions observed in the extended-spectrum ␤-lactamase (ESBL) TEM-12 and in the inhibitor-resistant penicillinase (IRT) TEM-33. This enzyme exhibited hydrolytic activity against ceftazidime and a low level of resistance to clavulanic acid. Surprisingly, the substitution Met69Leu enhanced the catalytic efficiency of oxyimino ␤-lactams conferred by the substitution Arg164Ser. Its discovery confirms the dissemination of the complex mutant group of TEM enzymes in European countries.
TEM-type ␤-lactamases are the most prevalent mechanism of resistance to ␤-lactam antibiotics in Enterobacteriaceae. Among these ␤-lactamases, extended spectrum ␤-lactamases (ESBL) and inhibitor-resistant penicillinases (IRT) have emerged from the parental penicillinases TEM-1 and TEM-2 (2) . Since the 1990s, another subgroup of enzymes that combine the substitutions observed in the ESBL and in the IRT appeared; its members were designated complex mutant TEM (CMT) (21) . Nine different CMT, mainly in E. coli strains, have been described: TEM-50, TEM-68, TEM-89, TEM-121, TEM-109, TEM-125, TEM-151, TEM-152, and TEM-158, most of which have been identified in France (7, 14, (16) (17) (18) (19) (20) (21) .
In 2004, during a 2-year study of ESBL-producing Enterobacteriaceae from different Portuguese clinical settings (12), Machado et al. identified a novel TEM enzyme that associated the Arg164Ser substitution observed in the ESBL TEM-12 (4) with the Met69Leu substitution observed in TEM-33 (IRT-5) (3). This ␤-lactamase, designated TEM-154, was produced by an Escherichia coli strain, H258, which is resistant to penicillins (alone or associated with clavulanic acid), ceftazidime, all tested aminoglycosides except amikacin, all tested quinolones, sulfamethoxazole, tetracycline, and chloramphenicol.
In this study, we characterized the genetic support and the enzymatic activity of TEM-154. E. coli H258 produces only one ␤-lactamase, which has a pI of 5.3. The French double-disk synergy test and CLSI MIC testing confirmed the production of an ESBL by this strain (5, 6) . The TEM-154-harboring plasmid did not transfer in mating experiments (19) . However, an E. coli DH5␣ transformant harboring the parental phenotype of resistance to ␤-lactams was obtained throughout electroporation of plasmid DNA. Plasmid DNAs were extracted from the clinical strain and transformant by the method of Kado and Liu (8) . Plasmid size was determined by comparison with those of plasmids Rsa (39 kb), TP114 (61 kb), pCFF04 (85 kb), and pCFF14 (180 kb), as previously described (15) . Plasmid content analysis revealed one plasmid of about 180 kb. TEM-specific PCR and sequencing experiments were performed on the clinical strain H258 and on the transformant as previously described (17) and confirmed the presence of bla . This gene harbored a pattern of silent mutations identical to those of bla TEM-1a and a promoting sequence, P a /P b (11) .
E. coli DH5␣ clones producing TEM-154, TEM-12, TEM-33, and TEM-1 were obtained using the vector pBK-CMV, as previously described (17) . The correct orientation of the different inserts was checked by PCR and sequencing using the primers pBK-CMV1Ј (5ЈCTAGTGGATCCAAGAATTCAA AAAGC3Ј) and pBK-CMV2Ј (5ЈAATTGGGTACACTTACC TGGTACCC3Ј). Direct sequencing of both strands was performed on two independent PCR products, which were obtained from the clinical strain E. coli H258 and from the different E. coli DH5␣ clones. The MICs for the clinical strain and the different E. coli DH5␣ clones are presented in Table 1 . E. coli DH5␣ clones, which produced the enzyme TEM-154 and its parental enzymes (TEM-12, TEM-33, and TEM-1) from the same genetic background, were used to compare microbiologically these related TEM-encoding genes, as previously described (17) . E. coli H258 and the corresponding clone had a high level of resistance to penicillins similar to that of the clones producing TEM-12, TEM-33, and TEM-1 (512 to Ͼ2,048 g/ml). The MICs of cephalothin, cefuroxime, cefoxitin, cefotaxime, and imipenem were similar for all E. coli DH5␣ clones. Only the TEM-154 and TEM-12 enzymes, which harbored ESBL-type mutations, conferred a high level of resistance to ceftazidime (32 to 512 g/ml). However, ceftazidime MICs were 2-to 4-fold higher for the TEM-154-producing E. coli clone than for the TEM-12-producing clone. Likewise, the MICs of cefepime and aztreonam for TEM-154-producing E. coli were close to those of the TEM-12-producing clone (1 to 2 g/ml) and higher than those for the TEM-1-and TEM-33-producing E. coli DH5␣ clones (0.06 to 0.12 g/ml).
Clavulanic acid did not restore the susceptibility of TEM-154-producing E. coli to penicillins, and the MICs of penicillinclavulanic acid combinations were even higher than those observed for the TEM-33-producing clone (1,024 to Ͼ1,024 versus 128 to 512 g/ml). Clavulanic acid decreased the MICs of oxyimino ␤-lactams for both TEM-154-and TEM-12-producing strains, but the ceftazidime-clavulanic acid MIC remained in the intermediate range for the TEM-154-producing clone, probably because of its high level of resistance to ceftazidime (512 versus 32 to 64 g/ml). Tazobactam restored the susceptibility to piperacillin of the TEM-154-producing strains, as was observed for the other TEM-producing clones.
TEM-33, TEM-12, and TEM-154 were overproduced in E. coli BL21(DE3), as previously described (17) . The different TEM enzymes were purified to homogeneity, and the level of purity was estimated to be Ͼ95% by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (1, 10) . Matrix-assisted laser desorption-time of flight mass spectra (MALDI-TOF MS) were acquired on a Voyager DE-PRO mass spectrometer (ABSciex, les Ulis, France) equipped with a delayed-extraction MALDI source and a pulsed nitrogen laser (337 nm). The purified proteins were resuspended in 5 mM ammonium hydrogen carbonate. Sinapinic acid was used as a matrix, and mass was measured using a peptide mixture (trypsinogen, enolase, bovine serum albumin; LaserBio Labs, Sophia-Antipolis, France) as an external standard as previously described (13) . MALDI-TOF MS values (28,882.0 Da, 28,830.6 Da, and 28,815.6 Da) were in excellent agreement with the calculated molecular masses of the mature proteins (28,888.9 Da, 28,837.9 Da, and 28,819.9 Da, respectively). Their kinetic parameters (Table 2) were determined by computerized microacidimetry as previously described (9) and compared with those previously determined for TEM-1 (21). The 50% inhibitory concentrations (IC 50 s) were determined, as previously described (21), with 100 M benzylpenicillin as the reporter substrate, 1 nM enzyme, and 10 min of incubation (complete inactivation).
TEM-154 had 1.8-to 72-fold-higher k cat values against penicillins than TEM-12 and TEM-33. However, its activity against all these substrates except ticarcillin was lower than that of the parental penicillinase, TEM-1. TEM-154 K m values against benzylpenicillin and amoxicillin were closer to those of TEM-33 and TEM-1 than to those of TEM-12, whereas its K m values against piperacillin and ticarcillin were the highest of the four enzymes.
TEM-154 hydrolytic activity against cephalothin was close to that of the ESBL TEM-12 and was lower than that of TEM-1. The K m value for this substrate was 3-to 4-fold lower than that of the three other enzymes. However, its K m decrease was probably too low to increase the cephalothin MIC for the TEM-154-producing clone.
Surprisingly, TEM-154 displayed hydrolytic activity close to that of TEM-12 against cefotaxime and aztreonam and even greater activity against ceftazidime and had lower K m values for these substrates. Overall, TEM-154 had higher catalytic efficiency than the ESBL TEM-12 against cefuroxime, cefotaxime, ceftazidime, and aztreonam, suggesting that the IRT-type substitution Met69Leu enhanced the activity against oxyimino ␤-lactams conferred by the substitution Arg164Ser. These enhanced catalytic efficiencies probably explained the MIC discrepancies of cefotaxime and ceftazidime observed for the clones which produced TEM-154 and TEM-12. However, the enhancement observed for cefuroxime was probably too low to increase the MIC for the TEM-154-producing strain.
Finally, TEM-154 exhibited higher susceptibility to clavulanic acid than TEM-33 and was less susceptible than TEM-12 and TEM-1 (IC 50 , 0.67 versus 0.02, 0.08, and 1.8 M). TEM-154 was as susceptible to tazobactam as TEM-12 and TEM-1 (IC 50 , 0.14 versus 0.13 and 0.13 M).
TEM-154 was the 10th member of the complex mutant sub- (13, (15) (16) (17) (18) (19) (20) . Such efficiency was similar to those of ESBL ceftazidimases such as TEM-6 and TEM-28 (k cat /K m , 0.4 and 0.27 M Ϫ1 ⅐ s Ϫ1 ) (18, 19) .
TEM-154 was slightly less resistant to clavulanate than IRT enzymes and conferred a high level of resistance to penicillinclavulanate acid combinations. However, this resistance level did not make it difficult to identify it as an ESBL, unlike with the CMT-type enzymes TEM-121, TEM-125, TEM-152, and TEM-158 (16) (17) (18) 20) . After the previous reports of CMT enzymes in France and in Poland (7, 14, (16) (17) (18) (19) (20) (21) , the discovery of this novel CMT in a Portuguese clinical setting confirms the emergence of this subgroup of TEM ␤-lactamases in Europe.
Nucleotide sequence accession number. The GenBank accession number for bla TEM-154 is FJ807656.
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